Subclinical hypothyroidism and cardiovascular risk: How to end the controversy

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 6, 2013, Pages 2267-2269

  Rodondi, Nicolas ^a   Bauer, Douglas C ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; THYROID HORMONE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ARTERIAL STIFFNESS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; EDITORIAL; HEART FAILURE; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERCOAGULABILITY; INFLAMMATION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; SUBCLINICAL HYPOTHYROIDISM; THROMBOSIS; THYROTROPIN BLOOD LEVEL;

FEMALE; HUMANS; HYPOTHYROIDISM; MYOCARDIAL INFARCTION;

EID: 84878496182     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1875     Document Type: Editorial

References (20)

1. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29:76-131. (Pubitemid 351252748)
2. Helfand M. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140:128-141.
3. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228-238. (Pubitemid 38082818)
4. Rodondi N, Aujesky D, Vittinghoff E, Cornuz J, Bauer DC. Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med. 2006;119:541-551. (Pubitemid 44041257)
5. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000;132:270-278. (Pubitemid 30106257)
6. Monzani F, Caraccio N, Kozakowa M, et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. J Clin Endocrinol Metab. 2004;89:2099-2106. (Pubitemid 38619837)
7. Rodondi N, Newman AB, Vittinghoff E, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med. 2005;165:2460-2466. (Pubitemid 41720006)
8. Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006;295:1033-1041.
9. Ochs N, Auer R, Bauer DC, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med. 2008;148:832-845. (Pubitemid 351786932)
10. Razvi S, Shakoor A, Vanderpump M, Weaver JU, Pearce SH. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab. 2008;93:2998-3007.
11. Simmonds MC, Higgins JP, Stewart LA, Tierney JF, Clarke MJ, Thompson SG. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials. 2005;2:209-217. (Pubitemid 40910470)
12. Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304:1365-1374.
13. Gencer B, Collet TH, Virgini V, et al. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation. 2012;126:1040-1049.
14. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab. 2007;92:1715-1723. (Pubitemid 46997177)
15. LeGrys VA, Funk MJ, Lorenz CE, et al. Subclinical hypothyroidism and risk for incident myocardial infarction among postmenopausal women. J Clin Endocrinol Metab. 2013;98:2308-2317.
16. Hyland KA, Arnold AM, Lee JS, Cappola AR. Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the Cardiovascular Health Study. J Clin Endocrinol Metab. 2013;98:533-540.
17. Fatourechi V, Lankarani M, Schryver PG, Vanness DJ, Long KH, Klee GG. Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5.1-10.0 mIU/L). Mayo Clin Proc. 2003;78:554-560. (Pubitemid 36529895)
18. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab. 2005;90:581-585; discussion 586-587.
19. Quinn TJ, Gussekloo J, Kearney P, Rodondi N, Stott DJ. Subclinical thyroid disorders. Lancet. 2012;380:335-336; author reply 336-337.
20. Nicholls M. Nicolas Rodondi: spotlight: investigating the relationships between thyroid dysfunction and cardiovascular disease, and testing the impact of treatment of thyroid dysfunction on clinical outcomes. Circulation. 2012;126:f127-f129.